These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3108922)

  • 1. Pharmacokinetics of haloperidol in psychotic patients.
    Cheng YF; Paalzow LK; Bondesson U; Ekblom B; Eriksson K; Eriksson SO; Lindberg A; Lindström L
    Psychopharmacology (Berl); 1987; 91(4):410-4. PubMed ID: 3108922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol kinetics after oral and intravenous doses.
    Holley FO; Magliozzi JR; Stanski DR; Lombrozo L; Hollister LE
    Clin Pharmacol Ther; 1983 Apr; 33(4):477-84. PubMed ID: 6831826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of route of administration on haloperidol plasma levels in psychotic patients.
    Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of haloperidol and reduced haloperidol in Chinese schizophrenic patients after intravenous and oral administration of haloperidol.
    Chang WH; Lam YW; Jann MW; Chen H
    Psychopharmacology (Berl); 1992; 106(4):517-22. PubMed ID: 1579624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination half-life and bioavailability of haloperidol in schizophrenic patients.
    Magliozzi JR; Hollister LE
    J Clin Psychiatry; 1985 Jan; 46(1):20-1. PubMed ID: 3965439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
    Trenk D; Wagner F; Sachs W; Jähnchen E
    Eur J Clin Pharmacol; 1989; 37(3):313-6. PubMed ID: 2612546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear pharmacokinetics of haloperidol in the rat.
    Cheng YF; Paalzow LK
    Biopharm Drug Dispos; 1992 Jan; 13(1):69-76. PubMed ID: 1554878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of oral ergometrine in male volunteers.
    de Groot AN; Vree TB; Hekster YA; van den Biggelaar-Martea M; van Dongen PW; van Roosmalen J
    Biopharm Drug Dispos; 1994 Jan; 15(1):65-73. PubMed ID: 8161717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of nutritional status on intravenous pharmacokinetics of haloperidol in psychotic patients].
    Donoso A; Vera G; Arancibia A; Díaz E; Schilkrut R; Miserda R; Kohen P; Pak N
    Rev Med Chil; 1984 Aug; 112(8):777-83. PubMed ID: 6533717
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration.
    Möller HJ; Kissling W; Lang C; Doerr P; Pirke KM; von Zerssen D
    Am J Psychiatry; 1982 Dec; 139(12):1571-5. PubMed ID: 7149056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies on haloperidol in man.
    Forsman A; Ohman R
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):319-36. PubMed ID: 822989
    [No Abstract]   [Full Text] [Related]  

  • 14. Yohimbine bioavailability in humans.
    Guthrie SK; Hariharan M; Grunhaus LJ
    Eur J Clin Pharmacol; 1990; 39(4):409-11. PubMed ID: 2076728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol pharmacokinetics: a preliminary study in rhesus monkeys using a new radioimmunoassay procedure.
    Stafford JE; Jackson LS; Forrest TJ; Barrow A; Palmer RF
    J Pharmacol Methods; 1981 Dec; 6(4):261-79. PubMed ID: 7334810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of dixyrazine: low bioavailability, improved by food intake.
    Liedholm H; Lidén A; Kroon L; Melander A; Wåhlin-Boll E
    Drug Nutr Interact; 1985; 3(2):87-92. PubMed ID: 3987521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of midazolam in man.
    Heizmann P; Eckert M; Ziegler WH
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):43S-49S. PubMed ID: 6138080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.